Target Healthcare REIT PLC (THRL.L)
GBp 84.4
(1.44%)
GBp 84.4
(1.44%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 42.34 Million | 29.66 Million | 30.39 Million | 24.95 Million | 21.46 Million | 18.16 Million |
| Net Income | 73.02 Million | -6.57 Million | 49.09 Million | 43.88 Million | 31.62 Million | 29.88 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 5.17 Million | -4.87 Million | -428 Thousand | -923 Thousand | -868 Thousand | -2.06 Million |
| Other non-cash items | 11.6 Million | 41.11 Million | -18.27 Million | -18 Million | -9.28 Million | -9.66 Million |
| Investing Cash Flow | 3.41 Million | -3.55 Million | -202.63 Million | -43.57 Million | -103.41 Million | -99.61 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -40.92 Million | -29.34 Million | -206.99 Million | -51.4 Million | -117.5 Million | -99.61 Million |
| Sales/Maturities of investments | 44.34 Million | 25.78 Million | 4.36 Million | 7.82 Million | 14.08 Million | - |
| Other Investing Activities | 3.41 Million | -3.55 Million | -202.63 Million | -43.57 Million | -103.41 Million | -99.61 Million |
| Financing Cash Flow | -22.24 Million | -45.22 Million | 185.61 Million | 3.28 Million | 91.44 Million | 66.99 Million |
| Debt repayment | -13 Million | -4.95 Million | -102.91 Million | -23.53 Million | -42.41 Million | -33.5 Million |
| Dividends payments | -35.24 Million | -40.27 Million | -39.78 Million | -31.49 Million | -29.15 Million | -23.62 Million |
| Common Stock Repurchased | - | - | -225.4 Million | -34.77 Million | -120.59 Million | -15.42 Million |
| Common Stock Issuance | - | - | 122.49 Million | 58.31 Million | 78.17 Million | 48.92 Million |
| Other Financing Activities | - | -4.95 Million | 431.22 Million | 34.77 Million | 205.42 Million | 90.62 Million |
| Accounts receivables | 3.08 Million | -4.55 Million | -5.01 Million | -2.78 Million | -1.23 Million | -2.06 Million |
| Accounts payables | 2.08 Million | -325 Thousand | 4.59 Million | 1.85 Million | 370 Thousand | 2.05 Million |
| Inventory | - | - | - | 1.55 Million | - | - |
| Other working capital | 2.08 Million | - | - | -1.55 Million | - | -2.05 Million |
| Cash at beginning of period | 15.36 Million | 34.02 Million | 19.33 Million | 16.54 Million | 8.62 Million | 41.4 Million |
| Cash at end of period | 38.88 Million | 17.04 Million | 34.02 Million | 19.33 Million | 16.54 Million | 26.94 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | 2.13 Million | 1.31 Million | 18.11 Million | -1.57 Million | - |
| Net cash flow / Change in cash | 23.51 Million | -16.98 Million | 14.69 Million | 2.78 Million | 7.91 Million | -14.45 Million |
| Free Cash Flow | 42.34 Million | 29.66 Million | 30.39 Million | 24.95 Million | 21.46 Million | 18.16 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 42.26 Million | 73.02 Million | 30.76 Million | -6.57 Million | 27.6 Million | -34.17 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 968 Thousand | 5.17 Million | 3.69 Million | -4.87 Million | -4 Million | -870 Thousand |
| Other non-cash items | -23.65 Million | 11.6 Million | -11.68 Million | 41.11 Million | -5.24 Million | 51.23 Million |
| Investing Cash Flow | 28.89 Million | 3.41 Million | -25.47 Million | -3.55 Million | 8.62 Million | -12.17 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -15.45 Million | - | -25.47 Million | -29.34 Million | -12.88 Million | -16.45 Million |
| Sales/Maturities of investments | 44.34 Million | - | - | 25.78 Million | 21.5 Million | 4.28 Million |
| Other Investing Activities | - | 3.41 Million | -25.47 Million | -3.55 Million | 8.62 Million | -12.17 Million |
| Financing Cash Flow | -27.21 Million | -22.24 Million | 4.97 Million | -45.22 Million | -29.4 Million | -15.82 Million |
| Debt repayment | -9.5 Million | -13 Million | -22.5 Million | -4.95 Million | -10 Million | -5.04 Million |
| Dividends payments | -17.71 Million | -35.24 Million | -17.53 Million | -40.27 Million | -19.4 Million | -20.87 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -4.95 Million | -10 Million | -205 Thousand |
| Accounts receivables | -614 Thousand | - | 3.69 Million | -4.55 Million | -4.03 Million | -512 Thousand |
| Accounts payables | 1.58 Million | - | 506 Thousand | -325 Thousand | 33 Thousand | -358 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 17.63 Million | 15.36 Million | 17.04 Million | 34.02 Million | 21.8 Million | 34.02 Million |
| Cash at end of period | 38.8 Million | 38.88 Million | 17.63 Million | 17.04 Million | 17.04 Million | 21.8 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -1.67 Million | 2.13 Million | -15.36 Million | 34.48 Million |
| Net cash flow / Change in cash | 21.17 Million | 23.51 Million | 591 Thousand | -16.98 Million | -4.76 Million | -12.21 Million |
| Free Cash Flow | 19.57 Million | 42.34 Million | 22.77 Million | 29.66 Million | 14.34 Million | 15.32 Million |
GRPLTD
RWA
GOOG
INS
002099
GLE